Article
Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease.
Nature communications - 25 Nov 2016
Ventham N T, Kennedy N A, Adams A T, Kalla R, Heath S, O'Leary K R, Drummond H, Wilson D C, Gut I G, Nimmo E R, Satsangi J
Abstract excerpt
Epigenetic alterations may provide important insights into gene-environment interaction in inflammatory bowel disease (IBD). Here we observe epigenome-wide DNA methylation differences in 240 newly-diagnosed IBD cases and 190 controls. These include 439 differentially methylated positions (DMPs) and 5 differentially methylated regions (DMRs), which we study in detail using whole genome bisulphite sequencing. We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
